Meet virtually with Cisco Webex. Anytime, anywhere, on any device.
Simple, modern video meetings for everyone on the world’s most popular and trusted collaboration platform.
Related Articles
Liver-Directed Therapies in Colorectal Cancer: Old Hats and New Tricks
Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a…
Podcast: ASCO25 Recap: CHALLENGE, DESTINY-Breast09, and More
Dr. John Sweetenham and Dr. Erika Hamilton highlight key abstracts that were presented at ASCO25, including advances in breast and pancreatic cancers as well as…
Surgical and Perioperative Advances for Patients With Locally Advanced Non–Small Cell Lung Cancer
Locally advanced non–small cell lung cancer (NSCLC) is primarily treated with multimodality therapy, which has undergone significant advancements over the years. Recently, the management of…
State of the Art: Therapies Now and Around the Corner for Gynecologic Cancers
Therapeutic advances across the gynecologic cancer continuum have resulted in improvements in patient care and outcomes over the past decade, yet challenges remain. In ovarian…
Peters Leads Colleagues to Reintroduce Bipartisan Bill to Strengthen Critical Drug Supply Chains and Mitigate Shortages – Committee on Homeland Security & Governmental Affairs
Legislation Would Help Build Reserves of Critical Medications with Vulnerable Supply Chains While Bolstering Domestic Manufacturing Capacity WASHINGTON, D.C. – U.S. Senators Gary Peters (D-MI),…
Long-Term Follow-Up Care After Treatment for Primary Breast Cancer: Strategies and Considerations
Advancements in early detection and multimodal treatment strategies have significantly improved survival rates for early-stage breast cancer, now exceeding 80% at 10 years. However, breast…
Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies | JCO Oncology Advances
PURPOSEThe onset of the COVID-19 pandemic in early 2020 disrupted the conduct of cancer clinical trials. In response, federal agencies allowed more flexibility for trial…
Second-Line Tarlatamab Shows Improved Survival Over Chemotherapy in Previously Treated SCLC
Results from the phase 3 DeLLphi-304 trial show improved OS and significantly longer PFS with the bispecific antibody tarlatamab versus standard-of-care chemotherapy in previously treated…
Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening
Lung cancer is one of the leading causes of cancer-related mortality worldwide, with most cases diagnosed at advanced stages where curative treatment options are limited.…